iRhythm Technologies

650 Townsend Street, Suite 380

San Francisco

California

94103

United States

(415) 632-5700

(415) 632-5701

[email protected]

http://www.irhythmtech.com

Related Content

Feature | Atrial Fibrillation

New Clues in Finding Silent Arrhythmias

Patients with type 2 diabetes (T2D) and chronic kidney disease (CKD) are at elevated risk for cardiovascular disease.1 ...

September 04, 2025

News | Patient Monitors

AVALON Study Builds on CAMELOT Study Reinforcing iRhythm’s LTCM Clinical Performance

Aug. 18, 2025 — iRhythm Technologies, Inc. has announced the publication of a real-world evidence study: Assessment of ...

August 19, 2025

News | Heart Failure

Study Highlights Burden, Risk of Cardiac Arrhythmias in Patients with Type 2 Diabetes and Chronic Kidney Disease

June 23, 2025 — iRhythm Technologies, Inc. announced the results from two large-scale real-world studies presented at ...

June 25, 2025

News | Remote Monitoring

iRhythm Presents New Data on Ambulatory Cardiac Monitoring

April 28, 2025 — iRhythm Technologies, Inc. recently announced results from a large real-world retrospective analysis ...

April 29, 2025

News | Holter Monitoring Systems

iRhythm Unveils New Data Demonstrating Benefits of Long-Term Continuous Monitoring for Arrhythmia Detection

March 31, 2025 — iRhythm Technologies, Inc. has announced results from two large real-world retrospective analyses ...

March 31, 2025

CE mark reinforces the Zio monitor system as a leading innovation in ambulatory cardiac monitoring and highlights the company’s commitment to providing the highest quality product and services globally

News | Wearables

iRhythm Technologies Receives European Union’s CE Marking Under Medical Device Regulation (EU MDR) for its Zio monitor and ZEUS System

January 3, 2024 — iRhythm Technologies, Inc., a leading digital health care company focused on creating trusted ...

January 03, 2024

Rhythm is launching its next generation long-term ambulatory cardiac monitor in the U.S.

News | Wearables

iRhythm Launches Next Generation Zio Monitor and Enhanced Zio Service

September 27, 2023 — iRhythm Technologies, Inc. announced the U.S. launch of its next-generation Zio monitor and ...

September 27, 2023

Clinical studies presented at Heart Rhythm 2023 build on the totality of clinical evidence that continue to highlight the value of iRhythm’s Zio products and services across a wide range of patient populations

News | ECG

New Data From iRhythm Reinforce the Utility of Long-Term Ambulatory Cardiac Monitoring for Increased Diagnostic Yield and Improved Diagnostic Accuracy of Actionable Arrhythmias

May 24, 2023 — Rhythm Technologies, Inc., a leading digital health care company focused on creating trusted solutions ...

May 24, 2023

News | Atrial Fibrillation

Zio by iRhythm Shown to Prevent Hospital Admissions, Aid in Early Detection of AF

April 12, 2022 – iRhythm Technologies, Inc., a leading digital healthcare solutions company focused on the advancement ...

April 12, 2022

iRhythm Technologies, Inc., a leading digital healthcare solutions company focused on the advancement of cardiac care, announced that the results of the KP-Rhythm2 study, titled “Diagnostic yield, outcomes and resource utilization with different ambulatory electrocardiographic monitoring strategies,” were published in the American Journal of Cardiology (AJC).

News | Atrial Fibrillation

Zio by iRhythm Shows Significantly Higher Documentation of Atrial Fibrillation and Atrial Flutter Compared to Holter Monitors, Event Monitors

February 28, 2022 – iRhythm Technologies, Inc., a leading digital healthcare solutions company focused on the ...

February 28, 2022